Resuscitative Endovascular Balloon Occlusion of the Aorta

Global Resuscitative Endovascular Balloon Occlusion of the Aorta Market to Reach ## by 2034

The global market for Resuscitative Endovascular Balloon Occlusion of the Aorta estimated at ## in the year 2024, is expected to reach ## by 2034, growing at a CAGR of 0.0% over the analysis period 2024-2034.

Global Resuscitative Endovascular Balloon Occlusion of the Aorta Market – Key Trends & Drivers Summarized

Why Is Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) Gaining Widespread Adoption in Trauma Care?

Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) has emerged as a life-saving intervention for trauma patients experiencing hemorrhagic shock due to severe abdominal, pelvic, or lower extremity injuries. Traditionally, uncontrolled bleeding in such cases has been managed through immediate open surgery, but REBOA offers a minimally invasive alternative that improves survival rates by temporarily controlling hemorrhage and stabilizing patients until definitive surgical treatment can be performed. The increasing incidence of traumatic injuries from road accidents, battlefield injuries, and industrial accidents has driven the demand for REBOA procedures in emergency and military medicine. Additionally, advancements in vascular access technology have made the procedure more accessible, increasing its adoption across trauma centers and pre-hospital care settings.

How Are Technological Innovations Enhancing the Efficiency and Safety of REBOA?

Innovations in catheter-based interventions and endovascular technology have significantly improved the efficacy and safety of REBOA procedures. The development of smaller, lower-profile balloon catheters has reduced complications associated with vascular access and prolonged occlusion times. Additionally, real-time imaging guidance and pressure monitoring systems are enabling more precise placement and inflation of the balloon, minimizing the risk of ischemic injury. Automated REBOA systems with wireless monitoring capabilities are also being explored, allowing clinicians to remotely adjust occlusion levels and optimize perfusion control. These technological advancements are making REBOA a more viable and safer option for trauma management, expanding its clinical applications beyond traditional emergency settings.

What Market Trends Are Driving the Expansion of the REBOA Market?

The growing emphasis on improving trauma care infrastructure has led to increased adoption of REBOA in both civilian and military healthcare settings. The integration of REBOA into pre-hospital emergency services, including ambulance and air-medical transport units, is further expanding its reach. Additionally, medical institutions are investing in REBOA training programs to equip trauma surgeons, emergency physicians, and critical care teams with the necessary skills to perform the procedure effectively. The rise of hybrid operating rooms and endovascular trauma management protocols has also facilitated the wider adoption of REBOA in tertiary care centers. Moreover, government funding and research initiatives aimed at reducing mortality from traumatic injuries are supporting the market`s growth.

What Are the Key Growth Drivers of the REBOA Market?

The growth in the global REBOA market is driven by increasing trauma-related fatalities, advancements in endovascular balloon occlusion technology, and the expansion of emergency trauma care infrastructure. The adoption of minimally invasive life-saving procedures, particularly in military and civilian trauma centers, has further accelerated demand. Additionally, ongoing clinical research into optimizing REBOA techniques and expanding its applications in non-trauma conditions, such as postpartum hemorrhage, is broadening its market potential. The integration of AI-powered monitoring systems and robotic-assisted vascular procedures is also expected to enhance the precision and safety of REBOA, fueling market expansion. As healthcare systems prioritize rapid intervention strategies for trauma patients, the REBOA market is poised for substantial growth, revolutionizing the field of emergency medicine.

SCOPE OF STUDY:

The report analyzes the Resuscitative Endovascular Balloon Occlusion of the Aorta market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
End-Use (Cardiac Arrest, Aortic Occlusion, Tactical Combat Casualty Care)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -
  • Abbott Laboratories
  • Acandis GmbH
  • AngioDynamics, Inc.
  • Asahi Kasei Corporation
  • Bentley InnoMed GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • BVM Medical Limited
  • Cardinal Health, Inc.
  • Cook Medical
  • Edwards Lifesciences Corporation
  • Emergency Scientific, LLC
  • Front Line Medical Technologies
  • Johnson & Johnson
  • Lepu Medical Technology
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Mermaid Medical Group
  • MicroPort Scientific Corporation
  • Oscor Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Resuscitative Endovascular Balloon Occlusion of the Aorta – Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence of Traumatic Hemorrhage and Non-Compressible Bleeding Conditions Drives REBOA Adoption
Increased Recognition of REBOA as a Life-Saving Pre-Hospital and Emergency Room Intervention Spurs Clinical Uptake
Technological Advancements in Balloon Catheter Design Enhance Ease of Deployment and Procedural Speed
Expansion of Trauma and Acute Care Surgery Programs Throws the Spotlight on Endovascular Resuscitation Devices
Surge in Combat and Military Applications Strengthens Business Case for REBOA in Battlefield Medicine
Regulatory Approvals for Low-Profile and Partial Occlusion Devices Expand Indication Spectrum
Growth in Emergency Medicine Residency Training Supports Familiarity and Usage of REBOA Systems
Integration of REBOA in Trauma Protocols and ATLS Guidelines Drives Hospital Adoption Rates
Increased Utilization in Obstetric Hemorrhage and Ruptured Aneurysm Cases Expands Off-Label Applications
Development of Zone-Specific Occlusion Strategies Enhances Targeted Hemodynamic Stabilization
Partnerships Between Device Manufacturers and Trauma Centers Accelerate Product Validation and Usage
Surging Demand for Hemorrhage Control in Civilian Mass Casualty Incidents Fuels Device Availability
Adoption of Portable and Ultrasound-Guided REBOA Techniques Expands Pre-Hospital Intervention Capabilities
OEM Investment in Simulation-Based Training Programs Promotes Safe Implementation Across Institutions
Rising Emphasis on Damage Control Resuscitation Supports Complementary Role of REBOA With Surgical Interventions
Improved Data From Prospective Trials Strengthens Clinical Confidence and Inclusion in Guidelines
Use of REBOA in Hybrid Operating Rooms and Angio Suites Increases Workflow Integration
Focus on Reducing Time-to-Intervention and Transport-Related Mortality Drives REBOA Training Among Paramedics
Global Expansion of Advanced Trauma Systems Opens Market for REBOA in Developing Countries
Adoption of Balloon Occlusion Techniques in Non-Traumatic Hemorrhagic Shock Supports Expanded Utility
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Resuscitative Endovascular Balloon Occlusion of the Aorta Market Analysis of Annual Sales in US$ for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 3: World 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Cardiac Arrest by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 5: World 6-Year Perspective for Cardiac Arrest by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 6: World Recent Past, Current & Future Analysis for Aortic Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 7: World 6-Year Perspective for Aortic Occlusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Tactical Combat Casualty Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 9: World 6-Year Perspective for Tactical Combat Casualty Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 10: USA Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 11: USA 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
CANADA
TABLE 12: Canada Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 13: Canada 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
JAPAN
Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 14: Japan Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 15: Japan 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
CHINA
Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 16: China Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 17: China 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
EUROPE
Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 18: Europe Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 19: Europe 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
TABLE 20: Europe Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 21: Europe 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
FRANCE
Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 22: France Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 23: France 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
GERMANY
Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 24: Germany Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 25: Germany 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
ITALY
TABLE 26: Italy Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 27: Italy 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
UNITED KINGDOM
Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 28: UK Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 29: UK 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
REST OF EUROPE
TABLE 30: Rest of Europe Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 31: Rest of Europe 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
ASIA-PACIFIC
Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 32: Asia-Pacific Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 33: Asia-Pacific 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
REST OF WORLD
TABLE 34: Rest of World Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 35: Rest of World 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings